In this issue of Urologic Clinics of North America, guest editor Dr. Mark L. Gonzalgo brings his considerable expertise to the topic of Current Management of Superficial Bladder Cancer. Non-muscle-invasive bladder cancer (NMIBC) represents approximately 75% of newly diagnosed bladder cancer cases, making its management a critical focus for urologists worldwide. In this issue, top experts address the evolving landscape of NMIBC care, from innovations in urinary biomarkers and enhanced cystoscopy techniques to advancements in intravesical therapies and personalized molecular treatment.
- Contains 14 relevant, practice-oriented topics, including emerging intravesical therapies for NMIBC; management of high-risk NMIBC; economic considerations in the management of superficial bladder cancer; artificial intelligence and digital tools in bladder cancer care; key clinical trials shaping the future of superficial bladder cancer management; and more
- Provides in-depth clinical reviews on current management of superficial bladder cancer, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
